SavedAdd your journal

Journals / Haydarpaşa Numune Medical Journal / 2021 / Cilt: 61 - Sayı: 4

Comparison of Accelerated Corneal Collagen Cross-Linking Methods

Mustafa Nuri ELÇİOĞLU
Serap YURTTAŞER OCAK
Fevziye ÖZDAVUT ASLAN
Pages
412–416
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Both methods seem to be effective in preventing keratoconus progression.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Our aim in this study was to compare the results of accelerated collagen cross-linking (CXL) treatments on visual acuity and topographic parameters in cases with progressive keratoconus.
📊
Key Findings & Data:Methods: The cases with the diagnosis of progressive keratoconus between January 2015 and January 2018, who underwent accelerated CXL, were analyzed retrospectively.
💡
Conclusion & Impact:Both methods seem to be effective in preventing keratoconus progression.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: Our aim in this study was to compare the results of accelerated collagen cross-linking (CXL) treatments on visual acuity and topographic parameters in cases with progressive keratoconus. Methods: The cases with the diagnosis of progressive keratoconus between January 2015 and January 2018, who underwent accelerated CXL, were analyzed retrospectively. Subjects who received 9 mW/cm² ultraviolet A (UV-A) treatment for 10 min and were treated with 18 mW/cm2 UV-A for 5 min were included in the study. Uncorrected visual acuity (UCVA), Uncorrected visual acuity (BCVA), refractive value changes (spherical, cylindrical values), and corneal topography values obtained using the Sirius device at preoperative and postoperative 1st, 3rd, 6th and 12th months (K1, K2, Kmaximum, anterior elevation, posterior elevation) were compared statistically. Results: A total of 80 eyes of 80 cases; 40 eyes treated with UV-A for 10 min and 40 eyes treated with UV-A for 5 min were included in the study. There was no difference between the two groups in terms of age and gender. There was a statistically significant increase in UCVA and BCVA (logMAR) values for both groups at the 6th and 12th months post-operatively when we compared the values before surgery (p0.05). Discussion and Conclusion: In cases of progressive keratoconus, 10-min 9 mW/cm² and 5-min 18 mW/cm² accelerated CXL methods showed similar results at the end of 1-year follow-up in terms of visual acuity improvement and topographic changes. Both methods seem to be effective in preventing keratoconus progression.

🔖

Cite This Article

ELÇİOĞLU, M. N., OCAK, S. Y., ASLAN, F. Ö. (2022). Comparison of Accelerated Corneal Collagen Cross-Linking Methods. Haydarpaşa Numune Medical Journal, Cilt: 61 - Sayı: 4, 412–416. https://ajindex.com/articles/535898

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Kirgiz A, Eliacik M, Yildirim Y. Different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus. Eye Vis (Lond) 2019;6:16
  2. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 2003;135:620–7
  3. Koç M, Uzel MM, Koban Y, Tekin K, Taşpınar AG, Yılmazbaş P. Accelerated corneal cross-linking with a hypoosmolar riboflavin solution in keratoconic thin corneas: Short-term results. Cornea 2016;35:350–4
  4. Hammer A, Richoz O, Mosquera SA, Tabibian D, Hoogewoud F, Hafezi F. Corneal biomechanical properties at different corneal cross-linking (CXL) irradiances. Investig Ophthalmol Visual Sci 2014;55:2881–4
  5. Cınar Y, Cingü AK, Türkcü FM, Çınar T, Yüksel H, Özkurt ZG, et al. Comparison of accelerated and conventional corneal collagen cross-linking for progressive keratoconus. Cutan Ocul Toxicol 2014;33:218–22
  6. Males J, Viswanathan D. Comparative study of long-term outcomes of accelerated and conventional collagen crosslinking for progressive keratoconus. Eye (Lond) 2018;32:32–8
  7. Hashemi H, Fotouhi A, Miraftab M, Bahrmandy H, Seyedian MA, Amanzadeh K, et al. Short-term comparison of accelerated and standard methods of corneal colagen crosslinking. J Cataract Refract Surg 2015;41:533–40
  8. Hashemi H, Miraftab M, Seyedian MA, Hafezi F, Bahrmandy H, Heidarian S, et al. Long-term results of an accelerated corneal cross-linking protocol (18 mW/cm2) for the treatment of progressive keratoconus. Am J Ophtalmol 2015;160:1164–70.e1
  9. Vanissa WS, Tommy CY, Yu M, Wong VW, Jhanji V. One-year outcomes of conventional and accelerated colagen crosslinking in progressive keratoconus. Sci Rep 2015;5:14425
  10. Shetty R, Pahuja NK, Nuijts RM, Ajani A, Jayadev C, Sharma C, et al. Current protocols of corneal collagen cross-linking: Visual, refractive and tomographic outcomes. Am J Ophthalmol 2015;160:243–9
  11. Alnawaiseh M, Rosentreter A, Böhm MR, Eveslage M, Eter N, Zumhagen L. Accelerated corneal collagen cross-linking for progressive keratoconus. Cornea 2015;34:1421–31
  12. Ng AL, Chan TC, Cheng AC. Conventional versus accelerated corneal collagen cross-linking in the treatment of keratoconus. Clin Exp Ophthalmol 2016;44:8–14
  13. Eliaçık M, Kırgız A. Accelerated (9 mW/cm²) collagen crosslinking therapy in progressive keratoconus: 12-month followup results. Med Res Rep 2018;1:15–9.